News Corporation Class A Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? News Corporation Class A Common Stock trades at $29.12 (market cap $16.14B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.68 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 3.6× News Corporation Class A Common Stock's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.33%). Which is the better fit depends on your goals — on Pluang, investors hold News Corporation Class A Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| NWSA | TAK | |
|---|---|---|
Market Cap | $16.14B | $58.74B |
Volume | 4,310,610 | 3,110,994 |
Sector | Media | Health |
52-Week High | $31.19 | $19.05 |
52-Week Low | $22.40 | $13.23 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $16.96B | $86.65B |
Dividend Yield | 0.69% | 3.33% |
Trailing returns across standard periods
Latest headlines on both assets
News Corporation operates businesses in news and information services, digital real estate, and book publishing. Its brands include Dow Jones, The Wall Street Journal, HarperCollins, Realtor.com, and realestate.com.au.
Read more on NWSA →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →